Barclays PLC Buys 214,830 Shares of agilon health, inc. (NYSE:AGL)

Barclays PLC grew its stake in shares of agilon health, inc. (NYSE:AGL) by 21.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,228,952 shares of the company’s stock after acquiring an additional 214,830 shares during the period. Barclays PLC owned about 0.30% of agilon health worth $4,830,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health during the 3rd quarter worth about $28,000. City State Bank bought a new position in shares of agilon health during the third quarter valued at approximately $52,000. Nisa Investment Advisors LLC purchased a new position in agilon health during the second quarter valued at approximately $60,000. Allspring Global Investments Holdings LLC raised its stake in agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after buying an additional 10,674 shares in the last quarter. Finally, Signaturefd LLC lifted its holdings in agilon health by 166.2% during the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after buying an additional 7,398 shares during the period.

Analyst Ratings Changes

Several research analysts have recently commented on AGL shares. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target for the company. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Stifel Nicolaus lowered their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Evercore ISI reduced their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Finally, Barclays lowered their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has an average rating of “Hold” and a consensus target price of $4.28.

agilon health Stock Up 4.8 %

AGL stock opened at $1.97 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm’s fifty day simple moving average is $2.32 and its 200-day simple moving average is $4.25. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $13.28. The company has a market capitalization of $811.68 million, a P/E ratio of -2.10 and a beta of 0.51.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the business posted ($0.06) earnings per share. As a group, equities research analysts forecast that agilon health, inc. will post -0.52 earnings per share for the current year.

Insider Activity at agilon health

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Diana Mckenzie acquired 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The stock was acquired at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 90,000 shares of company stock worth $198,100. 3.20% of the stock is owned by corporate insiders.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.